[go: up one dir, main page]

BRPI0513572A - composições e métodos para tratamento de sangramento excessivo - Google Patents

composições e métodos para tratamento de sangramento excessivo

Info

Publication number
BRPI0513572A
BRPI0513572A BRPI0513572-9A BRPI0513572A BRPI0513572A BR PI0513572 A BRPI0513572 A BR PI0513572A BR PI0513572 A BRPI0513572 A BR PI0513572A BR PI0513572 A BRPI0513572 A BR PI0513572A
Authority
BR
Brazil
Prior art keywords
compositions
methods
excessive bleeding
treating excessive
supramolecular
Prior art date
Application number
BRPI0513572-9A
Other languages
English (en)
Inventor
Henry Eisenson
Allan D Pronovost
Original Assignee
Allan D Pronovost
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allan D Pronovost filed Critical Allan D Pronovost
Publication of BRPI0513572A publication Critical patent/BRPI0513572A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sealing Devices (AREA)
  • Detergent Compositions (AREA)
  • Silicon Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçõES E MéTODOS PARA TRATAMENTO DE SANGRAMENTO EXCESSIVO o material da invenção é uma família única de selantes de ferimento utilizada externamente com base em um agente de ligação de partículas de sílica de submícron que, quando hidratado se aglomera sob a forma de uma rede entrecruzada supramolecular servindo como uma armação estrutural facilitando a formação de coágulo. Um acelerador de cascata trombolítica pode ser fornecido, opcionalmente com fatores de coagulação adicionais, para acelerar ainda mais o processo de coagulação.
BRPI0513572-9A 2004-07-22 2005-07-22 composições e métodos para tratamento de sangramento excessivo BRPI0513572A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59021404P 2004-07-22 2004-07-22
US59084504P 2004-07-23 2004-07-23
PCT/US2005/026105 WO2006012541A2 (en) 2004-07-22 2005-07-22 Compositions and methods for treating excessive bleeding

Publications (1)

Publication Number Publication Date
BRPI0513572A true BRPI0513572A (pt) 2008-05-06

Family

ID=35786734

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513572-9A BRPI0513572A (pt) 2004-07-22 2005-07-22 composições e métodos para tratamento de sangramento excessivo

Country Status (8)

Country Link
US (2) US20060034935A1 (pt)
EP (1) EP1799192A2 (pt)
JP (1) JP2008507362A (pt)
BR (1) BRPI0513572A (pt)
CA (1) CA2574773A1 (pt)
IL (1) IL180844A0 (pt)
MX (1) MX2007000918A (pt)
WO (1) WO2006012541A2 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004030264D1 (de) * 2003-09-12 2011-01-05 Z Medica Corp Teilweise hydriertes hämostatisches mittel
US20060178609A1 (en) * 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
KR20070117589A (ko) 2005-02-15 2007-12-12 버지니아 커먼웰스 유니버시티 급성 지혈 및 급성 상처와 만성 궤양의 치료를 위한 광물기술
US9326995B2 (en) * 2005-04-04 2016-05-03 The Regents Of The University Of California Oxides for wound healing and body repair
US7691127B2 (en) * 2005-12-13 2010-04-06 Cardiva Medical, Inc. Drug eluting vascular closure devices and methods
US20100168767A1 (en) * 2008-06-30 2010-07-01 Cardiva Medical, Inc. Apparatus and methods for delivering hemostatic materials for blood vessel closure
US9179897B2 (en) * 2005-12-13 2015-11-10 Cardiva Medical, Inc. Vascular closure devices and methods providing hemostatic enhancement
US8911472B2 (en) 2005-12-13 2014-12-16 Cardiva Medical, Inc. Apparatus and methods for delivering hemostatic materials for blood vessel closure
US8938898B2 (en) * 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7981949B2 (en) * 2006-05-23 2011-07-19 3M Innovative Properties Company Curable hydrophilic compositions
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
WO2008036225A2 (en) * 2006-09-20 2008-03-27 Entek Manufacturing, Inc. Conformable structured therapeutic dressing
US20090148502A1 (en) * 2006-10-23 2009-06-11 Hemo Nanoscience, Llc Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US8703634B2 (en) * 2007-02-21 2014-04-22 The Regents Of The University Of California Hemostatic compositions and methods of use
US20080317831A1 (en) * 2007-06-21 2008-12-25 Denny Lo Hemostatic sponge and method of making the same
US20090047366A1 (en) * 2007-08-15 2009-02-19 Bedard Robert L Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants
US20090162406A1 (en) * 2007-09-05 2009-06-25 Z-Medica Corporation Wound healing with zeolite-based hemostatic devices
US8319002B2 (en) 2007-12-06 2012-11-27 Nanosys, Inc. Nanostructure-enhanced platelet binding and hemostatic structures
WO2009073854A1 (en) 2007-12-06 2009-06-11 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
US20090175926A1 (en) * 2008-01-08 2009-07-09 Adams Theodore P Topical burn treatment
US8795718B2 (en) * 2008-05-22 2014-08-05 Honeywell International, Inc. Functional nano-layered hemostatic material/device
US9119897B2 (en) * 2009-05-28 2015-09-01 Profibrix B.V. Dry powder fibrin sealant
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
JP5663806B2 (ja) * 2010-08-06 2015-02-04 独立行政法人産業技術総合研究所 カーボンナノチューブの安価な分離方法と分離材並びに分離容器
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
JP5801590B2 (ja) * 2011-04-11 2015-10-28 シスメックス株式会社 生体成分測定方法
US8586324B2 (en) 2011-08-15 2013-11-19 Biomet Biologics, Llc Method and apparatus to create autologous clotting serum
SG10201610469QA (en) 2011-11-13 2017-02-27 Cresilon Inc In-situ cross-linkable polymeric compositions and methods thereof
GB201201751D0 (en) 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
EP2863961B1 (en) 2012-06-22 2018-08-29 Z-Medica, LLC Hemostatic devices
US8871186B2 (en) * 2012-08-21 2014-10-28 Red Lion Chem Tech, Llc Compositions and methods for control of malodor and other environmental contaminants
US9861531B2 (en) * 2013-06-18 2018-01-09 Sanko Tekstil Isletmeleri Sanayi Ve Ticaret Anonim Sirketi Multi-function emergency bandage
EP2857350A1 (en) * 2013-09-10 2015-04-08 ESPCI Innov Use of nanoparticles for gluing gels
ES2941651T3 (es) * 2013-12-10 2023-05-24 Inst Nat Sante Rech Med Procedimientos para adherir superficies tisulares y materiales y usos biomédicos de los mismos
GB201400292D0 (en) 2014-01-08 2014-02-26 Haemostatix Ltd Peptide dendrimers and agents
AU2016214119B2 (en) * 2015-02-03 2020-10-22 Matoke Holdings Limited Antimicrobial fibers and compositions
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
KR102518121B1 (ko) 2015-06-22 2023-04-05 크레실론, 인코퍼레이티드 고효율 지혈용 접착제 조성물 스캐폴드
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
US20220211898A1 (en) * 2019-09-10 2022-07-07 American Nano, LLC Silica fiber hemostatic devices and methods
CA3153413A1 (en) * 2019-09-10 2021-03-18 American Nano, LLC Silica fiber hemostatic devices and methods
CN116212086B (zh) * 2022-11-17 2024-08-06 青岛海诺生物工程有限公司 一种防水透气创可贴及其制备工艺

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373519A (en) * 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4455377A (en) * 1982-05-07 1984-06-19 Cooper Laboratories, Inc. Clotting assay and reagent therefor
US4683157A (en) * 1982-11-15 1987-07-28 Mosser Mark F Thixotropic coating compositions and methods
USRE32991E (en) * 1984-11-13 1989-07-18 Thermedics, Inc. Drug dispensing wound dressing
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5292333A (en) * 1991-09-05 1994-03-08 Beth Israel Hospital Biological tissue adhesion
ES2227542T3 (es) * 1993-11-03 2005-04-01 Clarion Pharmaceuticals, Inc. Parche hemostatico.
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5981621A (en) * 1996-02-29 1999-11-09 Closure Medical Corporation Monomeric compositions effective as wound closure devices
US5645859A (en) * 1995-10-02 1997-07-08 Isp Investments Inc. Process for producing an alpha or beta-hydroxy acid-vinylpyrrolidone polymer, copolymer or graft polymer complex in the form of free-flowing powders having a high acid loading
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
US6168788B1 (en) * 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
US6323271B1 (en) * 1998-11-03 2001-11-27 Arteva North America S.A.R.L. Polyester resins containing silica and having reduced stickiness
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
US20020141964A1 (en) * 2001-01-19 2002-10-03 Patterson James A. Composition for arresting the flow of blood and method
US6607631B1 (en) * 2000-09-08 2003-08-19 Closure Medical Corporation Adhesive compositions with reduced coefficient of friction
EP1409028A4 (en) * 2000-10-13 2005-07-20 On Site Gas Systems Inc BANDAGE USING MOLECULAR SIEVES
US6586483B2 (en) * 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
JP2004530777A (ja) * 2001-06-28 2004-10-07 ビーエーエスエフ アクチェンゲゼルシャフト 酸性の高膨潤性ヒドロゲル
DE10145266A1 (de) * 2001-09-14 2003-04-24 Basf Coatings Ag Polyurethane und Pfropfmischpolymerisate auf Polyurethanbasis sowie ihre Verwendung zur Herstellung von Beschichtungsstoffen, Klebstoffen und Dichtungsmassen
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas

Also Published As

Publication number Publication date
WO2006012541A8 (en) 2007-04-26
WO2006012541A2 (en) 2006-02-02
CA2574773A1 (en) 2006-02-02
JP2008507362A (ja) 2008-03-13
MX2007000918A (es) 2007-12-04
EP1799192A2 (en) 2007-06-27
US20100047352A1 (en) 2010-02-25
US20060034935A1 (en) 2006-02-16
WO2006012541A3 (en) 2006-07-20
IL180844A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
BRPI0513572A (pt) composições e métodos para tratamento de sangramento excessivo
ATE518905T1 (de) Blasmittelzusammensetzung aus hydrofluorpropen und hydrochlorfluorolefin
CR8823A (es) Metodos y composiciones para la cicatrizacion de heridas
DE60138362D1 (de) Bioadhäsive zusammensetzung
GT200500114A (es) Composiciones y metodos para tratar materiales a base de celulosa con aditivos micronizados
ATE500839T1 (de) Verfahren und verbindungen zur unterdrückung der fibrocyten-differenzierung
BRPI0600165A (pt) processo de produção de um pneumático
BR0114221B1 (pt) composição de gesso, processo para fabricação de uma composição de gesso, chapa de gesso e processo para fabricação de chapa de gesso.
ECSP045467A (es) Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes
AR055907A1 (es) Procedimiento para fabricar un revestimiento bituminoso con prerrevestimiento
CL2009000647A1 (es) Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
BRPI0607280A2 (pt) método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento
WO2005030120A3 (en) Antiangiogenic agents
WO2009017863A3 (en) Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
BRPI0516680A (pt) injeção de selante de fibrina usando componentes reconstituìdos em aplicações espinais
EP1934025A4 (en) PREPARATION FOR WOOD TREATMENT, WOOD TREATMENT METHOD AND WOOD PRODUCT
BR112014013641A2 (pt) composição de polímero curável, e, compósito
BR0115337A (pt) Método para fabricar um compósito fibroso celulósico, compósito fibroso celulósico, e, espuma
BRPI0516673A (pt) injeção de selante de fibrina incluindo um anestésico em aplicações espinais
BRPI0511491A (pt) fibra polimérica carregada, utilização da mesma, produto à base de fibras, processo de fabricação de uma fibra polimérica carregada, e de um produto à base de fibras e de uma massa de pega hidráulica, e composição
BRPI0514922A (pt) processo para a produção de um material básico revestido para uma composição hidráulica, material básico revestido para uma composição hidráulica, aditivo para uma composição hidráulica e processo para a produção de uma composição hidráulica
BR0309788A (pt) Método de incorporação de um material em um aglutinante consolidável
DK1485059T3 (da) Topisk dapson til behandling af akne
AR033863A1 (es) Una composicion de blanqueo con aire, que tiene mejoradas propiedades de almacenamiento, y un procedimiento para preparar dicha composicion
EP3835348A4 (en) USE OF AN ETHOXYAMIDE POLYMER AS A COMBUSTION SLOWING AGENT, POLYOLEFINIC COMPOSITION SLOWING LOW ODOR COMBUSTION AND ITS PREPARATION PROCESS

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]